Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.83
+0.04 (0.69%)
At close: Aug 7, 2026, 4:00 PM EDT
5.75
-0.08 (-1.37%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $1.48 billion as of August 7, 2026. Its market cap has increased by 216.80% in one year.
Market Cap
1.48B
Enterprise Value
1.30B
1-Year Change
216.80%
Ranking
Category
Stock Price
$5.83
ChartMarket Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.48B, an increase of 1,014.16%. That is a compound annual growth rate of 29.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 1.19B | -3.29% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.51B |
| Xencor | 1.47B |
| MoonLake Immunotherapeutics | 1.45B |
| ArriVent BioPharma | 1.43B |
| Absci | 1.42B |
| Avalyn Pharma | 1.42B |
| ORIC Pharmaceuticals | 1.34B |
| Immatics | 1.34B |